First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Large Volume Increase

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw an uptick in trading volume on Tuesday . 13,001 shares changed hands during trading, a decline of 55% from the previous session’s volume of 28,615 shares.The stock last traded at $145.17 and had previously closed at $145.05.

First Trust NYSE Arca Biotechnology Index Fund Stock Down 0.7 %

The company has a market capitalization of $1.31 billion, a PE ratio of 17.74 and a beta of 0.79. The firm’s 50 day simple moving average is $151.33 and its 200 day simple moving average is $148.31.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

A number of large investors have recently made changes to their positions in FBT. SRS Capital Advisors Inc. lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 980.0% in the first quarter. SRS Capital Advisors Inc. now owns 162 shares of the company’s stock worth $25,000 after acquiring an additional 147 shares during the period. Independence Bank of Kentucky purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the first quarter worth about $31,000. Principal Securities Inc. purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth about $32,000. Dagco Inc. purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth about $50,000. Finally, International Assets Investment Management LLC purchased a new stake in First Trust NYSE Arca Biotechnology Index Fund in the third quarter worth about $62,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.